EVOFEM BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 7.01. Regulation FD Disclosure.

On November 15, 2021, Evofem Biosciences, Inc. (the "Company") utilized a slide presentation in conjunction with a conference call discussing its financial results for the fiscal third quarter ended September 30, 2021. The Company is posting these slides to the Events and Presentations page of its website at www.evofem.com, which can be accessed directly at https://evofem.investorroom.com/2021Q3Results.

These slides are attached to this Current Report on Form 8-K as Exhibit 99.1. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

Item 9.01.     Financial Statements and Exhibits.



(d) Exhibits
Exhibit No.    Description
99.1             Corporate presentation prepared as of November 15, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses